| Chronic Obstructive Pulmonary Disease |
1 |
1 |
| Lung Transplantation |
0 |
0.72 |
| Lung |
0 |
0.59 |
| Pulmonary Hypertension |
0 |
0.99 |
| Pulmonary Arterial Hypertension |
0 |
0.75 |
| Grant |
0 |
0.29 |
| Transplantation |
0 |
0.29 |
| Heart Failure (HF) |
0 |
0.22 |
| Idiopathic Pulmonary Arterial Hypertension |
0 |
0.8 |
| Endothelin Receptor Antagonists |
0 |
0.14 |
| Hypertension |
0 |
0.14 |
| Artery |
0 |
0.1 |
| Board Certification |
0 |
0.1 |
| Capillary |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Emphysema |
0 |
0.1 |
| Exercise |
0 |
0.1 |
| Hemodynamics |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Hypercapnia |
0 |
0.1 |
| Hypoxia |
0 |
0.1 |
| Impairment |
0 |
0.1 |
| Moderate COPD |
0 |
0.1 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.1 |
| Prognosis |
0 |
0.1 |
| Receptors |
0 |
0.1 |
| Rhode Island |
0 |
0.1 |
| Salary and Compensation |
0 |
0.1 |
| Severe COPD |
0 |
0.1 |
| Tolerance |
0 |
0.1 |
| Travel Medicine |
0 |
0.1 |
| Revenue and Practice Management |
0 |
0.04 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.02 |
| HIV Infection |
0 |
0.02 |